Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. (Q43278321)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Arun V Krishnan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Susanna B Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

David Goldstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Michael L Friedlander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Matthew C Kiernan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

10 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

Pt 10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

2712-2723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19745023%20AND%20SRC:MED&resulttype=core&format=json

The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Permeation of proteins from the blood into peripheral nerves and ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Threshold tracking techniques in the study of human peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Excitability of human axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Sensory conduction of the sural nerve in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin-safety profile: neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Excitability properties of motor axons in patients with spontaneous motor unit activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

The pathophysiology of oxaliplatin-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin-induced neurotoxicity and the development of neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin and axonal Na+ channel function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Assessment of nerve excitability in toxic and metabolic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Conduction block and impaired axonal function in tick paralysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Voluntary contraction impairs the refractory period of transmission in healthy human axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

The effects of mexiletine on excitability properties of human median motor axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Mechanism of calcium entry during axon injury and degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Motor axon excitability during Wallerian degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

About the role of visual field defects in pure alexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Grading of chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Effects of temperature on neuromuscular electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Axonal conduction and injury in multiple sclerosis: the role of sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219

Acute oxaliplatin-induced peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP219